WOCKHARDT
|
The Current P/E Ratio of WOCKHARDT is -130.27.
Share Price | ₹1,515.1 | Feb 12,2025 |
Market Cap | ₹24,620.4 Cr | |
Earnings-TTM | ₹-189.0 Cr | TTM-Consolidated Results |
Price/Earnings | -130.27x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of WOCKHARDT
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹24,620.4 Cr] as on Feb 12,2025
(/) Earnings [ ₹-189.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -130.27x ]
Thus, for WOCKHARDT , the investors are currently willing to pay -130.27 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of WOCKHARDT !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of WOCKHARDT over the last five years.
Historical PE (Price/Earnings) ratio chart of WOCKHARDT
PE Ratio Performance Analysis for WOCKHARDT
- WOCKHARDT 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.22x.
- WOCKHARDT 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WOCKHARDT 's p/e ratio peaked in Mar2021 at 6.12x.
- WOCKHARDT 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does WOCKHARDT 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
WOCKHARDT | -189.00 | -130.27 | 24,620.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 35.38 | 406,363.0 |
CIPLA LTD | 5,000.43 | 23.42 | 117,088.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.69 | 101,458.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 20.47 | 94,002.4 |
DIVIS LABORATORIES LTD | 2,067.00 | 76.63 | 158,396.0 |
MANKIND PHARMA LTD | 2,050.73 | 48.71 | 99,899.7 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 55.68 | 103,668.0 |
LUPIN LTD | 2,892.10 | 31.96 | 92,432.8 |
AUROBINDO PHARMA LTD | 3,500.25 | 19.00 | 66,513.4 |
ABBOTT INDIA LTD | 1,334.46 | 45.81 | 61,133.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs WOCKHARDT 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -130.27x |
Max industry PE | 76.63x |
Median industry PE | 31.96x |
Average industry PE | 22.32x |
You may also like the below Video Courses